Juluca

dolutegravir + rilpivirine · ViiV Healthcare

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Juluca, covering 2017-10-24 to 2025-11-14. Get the full timeline:

Most recent: EMA Authorised: Juluca (dolutegravir sodium;rilpivirine hydrochloride) — ViiV Healthcare B.V.